TALLAHASSEE, Fla. (FNN) – The heads of two of the major cancer institutions in Florida presented how research in the state is up to now, in a hearing before the Health Care Appropriations Subcommittee of the Florida House of Representatives in Tallahassee.
Dr. Stephan Neimer, director of the University of Miami Comprehensive Care Center, explained that since the Florida Consortium of National Cancer Institute was created in 2014, they have garnered $581 million in funds, recruited 274 specialists from all over the United States to the state, offered 45,706 training experiences, increased the number of patients in 136% and created 75 collaborative institutes.
Dr. Neimer added that they have collaborated closely with historic Black and Hispanic universities as well, saying that they have been “very strong” in building cancer research.
“Cancer has been our pandemic for decades and decades, we have great humility when it comes to cancer,” he added.
As far as vaccinating cancer patients against COVID-19, Dr. Neimer indicated that they have followed the State’s guidelines “strictly,” having received the Pfizer vaccine for health workers and Moderna for patients over 65 years old.
Dr. Daniel Armstrong, chairman of the Florida Biomedical Research Advisory Committee, added that funding for the National Institute of Health centers in the state has increased steadily since 2013, from $434 million that year to over $700 million in 2020.
There are currently 94 active funds, mostly aimed at improved care and increasing research as well.
Juan Carlo Rodriguez is a politics and entertainment reporter for Florida National News. | firstname.lastname@example.org